Surgery. The entire melanoma is cut out, along with a border (margin) of normal-appearing skin.
Chemotherapy, which uses medicines to stop or slow the growth of cancer cells.
Immunotherapy, which uses medicines to help your body's immune system fight the cancer.
Targeted therapy with inhibitors. These are medicines that inhibit, or prevent, cancer cells from growing by blocking signals in the cell. Inhibitors are only given if a gene test shows that a person has the BRAF gene change, or mutation.
Treatment will vary depending on the phase of disease, general health and age. During the chronic phase, treatment is used to control CML and keep your blood counts within a normal range. This can involve chemotherapy, usually taken in tablet form at home. Treatment is likely to involve the use of a type of tyrosine kinase inhibitor (TKI) - which blocks the leukaemia-causing effects of a substance called a tyrosine kinase, forcing the cell to then die. Commonly used tyrosine kinases available in Australia include: imatinib, nilotinib, and dasatinib. A stem cell transplant may be an option for some younger patients, or patients who are intolerant or resistant to TKIs - providing them with a better chance of cure.
The standard treatment for chronic phase CML is a tyrosine kinase inhibitor (TKI) such as imatinib (Gleevec), nilotinib (Tasigna), or dasatinib (Sprycel). For imatinib, the usual starting dose is 400 mg per day.
Test Method 1 : A sample of your blood will be needed to perform the test. The blood is tested with compounds that will react with antibodies in your blood.
The blood sample is obtained through ñvenipuncture, î in which a needle is inserted into a vein in your arm or hand. The needle draws a small amount of blood into tubing, and the sample is stored in a test tube.